Metapines
VerifiedNovel pharmaceutical composition for cancer treatment, where different compounds are simultaneously uptaken into cancer cells.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$67—101m (Dealroom.co estimates Apr 2022.)
Seongnam-si South Korea (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
* | KRW20.0b | Series B | |
| Total Funding | 000k | ||